Cryo Cell International (CCEL) Cash & Current Investments (2010 - 2026)

Cryo Cell International (CCEL) has reported Cash & Current Investments for 17 consecutive years, with $3.2 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash & Current Investments fell 28.64% year-over-year to $3.2 million; the TTM figure through May 2026 stood at $3.2 million (down 28.64% YoY), while the FY2025 annual figure was $3.3 million, down 5.72% from the prior year.
• Cash & Current Investments rose to $3.2 million in Q2 2026 per CCEL's latest filing, from $2.9 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $4.4 million in Q2 2025 and bottomed at $979593.0 in Q1 2024.
• Historically, Cash & Current Investments has averaged $2.5 million across 5 years, with a median of $2.7 million in 2022.
• Annual changes were most pronounced in 2022 — Cash & Current Investments slumped 79.35% — and 2024, when it surged 256.66%.
• Cryo Cell International's Cash & Current Investments stood at $1.7 million in 2022, then tumbled by 43.06% to $980250.0 in 2023, then soared by 256.66% to $3.5 million in 2024, then fell by 5.72% to $3.3 million in 2025, then fell by 4.07% to $3.2 million in 2026.
• Business Quant data shows CCEL's Cash & Current Investments at $3.2 million in Q2 2026, $2.9 million in Q1 2026, and $3.3 million in Q4 2025.